RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma. - Emde-Rajaratnam M; Beck S; Benes V; Salwender H; Bertsch U; Scheid C; Hänel M; Weisel K; Hielscher T; Raab MS; Goldschmidt H; Jauch A; et al. (Frontiers in immunology, 2023)